NFKB2 and lung carcinoma: To determine whether the decrease in B cells is the mechanism underlying the decreased lung cancer in NF-κB2–KO mice, B cells were depleted from WT mice with anti-CD20 antibodies starting before lung cancer induction (Figure 3B).